From the 15 most consistently reported dysregulated proteins, mutations in B2M, ALDH18A1, and IRF4 were reported in the A53, N1, and MCD subtypes of DLBCL, respectively. This evidence concerns the gene IRF4 and diffuse large B-cell lymphoma.